Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function

Gut

Volumn 52, Issue 2, 2003, Pages 218-223

  Clemente, M G ^a,b   De Virgiliis, S ^b   Kang, J S ^a,c   Macatagney, R ^a   Musu, M P ^b   Di Pierro, M R ^a   Drago, S ^a   Congia, M ^b   Fasano, A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; GLIADIN; PROTEIN; PROTEIN KINASE C; UNCLASSIFIED DRUG; ZONULIN PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOSKELETON; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; INCUBATION TIME; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; TIGHT JUNCTION;

ACTINS; ANIMALS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHOLERA TOXIN; CYCLOHEXIMIDE; CYTOSKELETON; ENTEROCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIADIN; MALE; MICROSCOPY, FLUORESCENCE; POLYMERS; PROTEIN KINASE C; RABBITS; RATS; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE;

EID: 0037302604     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.2.218     Document Type: Article

References (30)

1. Trier JS. Diagnosis of celiac sprue. Gastroenterology 1998;115:211-16.
2. Schuppand D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
3. Molberg O, Mcadam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in coeliac disease. Nat Med 1998;4:713-17.
4. Pender SL, Tickle SP, Docherty AJ, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-190.
5. Fasano A. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases. Mol Genet Metab 1998;64:12-18.
6. Cooper BT. Intestinal permeability in coeliac disease. Lancet 1983;1:658-9.
7. Bjarnason I, Peters TJ, Veall N. Intestinal permeability defect in coeliac disease. Lancet 1983;1:1284-5.
8. Schulzke JD, Bentzel CJ, Schulzke I, et al. Epithelial tight junctian structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998;43:435-41.
9. Wang W, Uzzau S, Goldblum SE, et al. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000;113:(pt 24)4435-40.
10. Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000;355:1518-19.
11. Lu R, Wang W, Uzzau S, et al. Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J Neurochem 2000;74:320-6.
12. Mays RW, Beck Ka, Nelson WJ. Organization and function of the cytoskeleton in polarized epithelial cell as component of the protein sorting machinery. Curr Opin Ceil Biol 1994;6:16-24.
13. Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction. J Biol Chem 1999;274:35179-85.
14. Fasano A, Fiorentini C, Donelli G, et al. Zonula occludens toxin (Zot) modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995;96:710-20.
15. Kwiatkowska K, Sobota A. Signaling pathways in phagocytosis. Bioessays 1999;21:422-31.
16. Di Pierro M, Lu R, Uzzau S, et al. Zonula occludens toxin structure-function analysis: identification of the Fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001;276:19160-5.
17. Uzzau S, Lu R, Wang W, et al. Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines. FEMS Microbiol Lett 2001;194:1-5.
18. Fosono A. Intestinal zonulin: open sesame! Gut 2001;49:159-62.
19. Brandtzaeg P, Halstensen TS, Kett K, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562-84.
20. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989;146:13-25.
21. Bjorkrnan PJ, Saper MA, Samraoui B, et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-12.
22. Bjorkman PJ, Saper MA, Samraoui B, et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-18.
23. Cuvelier C, Mielants H, De Vos M, et al. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 1990;31:545-9.
24. Wendling D. Role of the intestine in the physiopathology of inflammatory rheumatism. Rev Rhum Mal Osteoartic 1992;59:389-92.
25. Bjarnson I, Williams P, Smethurst P, et al. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986;27:1292-7.
26. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Dig Dis 1986;4:83-92.
27. Fasano A. Pathological and therapeutical implications of macromolecules passage through the tight junction. In: Cereijido M, Anderson J, eds. Tight junctions. CRC Press, 2001:697-722.
28. Madara JL, Trier JS.Structural abnarmalities of jejunal epithelial cell membranes in celiac sprue. Lab Invest 1980; 43:254-61.
29. Schulzke JD, Bentzel CJ, Schulzke I, et al. Epithelial tight junctian structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998;43:435-41.
30. Fasano A, Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administratian of insulin and ather macromolecules in an animal model. J Clin Invest 1997;99:1158-64.